Hexadiline

This classification denotes a vasodilating agent with the molecular formula C19H33N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z5T8Q3G88U, chemically known as 2-(2,2-dicyclohexylvinyl)piperidine but generally known as hexadiline, which bears US NIH Compound Identifier 219119. European Medicines Agency schedules Hexadiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08025MIG. The term HEXADILINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). HEXADILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hexadiline under HS 29333999 and SITC 51574. As of Q4 2014, HEXADILINE remains the US FDA Preferred Term for this commodity. Hexadiline bears US NLM identifiers UMLS ID C2827169 and NCI Concept Code C83749. SMILES: N1C(/C=C(/C2CCCCC2)C2CCCCC2)CCCC1.